Gen Kida
Saitama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Biological impact of chemotherapy during treatment with EGFR tyrosine kinase inhibitors for non-small cell lung cancer positive for EGFR activating mutations.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 05, 2025
Durvalumab after concurrent chemoradiotherapy for sensitizing epidermal growth factor receptor-mutant stage III non-small cell lung cancer: A Japanese Real-World data analysis.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 09, 2025
Successful surgical treatment of epithelioid hemangioendothelioma involving multiple liver lesions and bilateral lung nodules.
Journal: Respiratory medicine case reports
Published: July 31, 2022
Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax.
Journal: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Published: March 16, 2021
Hairspray Inhalation-induced Interstitial Pneumonitis Evaluated by a Transbronchial Lung Cryobiopsy.
Hairspray Inhalation-induced Interstitial Pneumonitis Evaluated by a Transbronchial Lung Cryobiopsy.
Journal: Internal medicine (Tokyo, Japan)
Published: February 22, 2021
Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancer.
Journal: Respiratory medicine case reports
Published: April 26, 2020
Nivolumab-induced contact dermatitis in a patient with advanced lung cancer.
Journal: Respiratory medicine case reports
Published: February 07, 2020
Autoimmune pulmonary alveolar proteinosis developed during immunosuppressive treatment in polymyositis with interstitial lung disease: a case report.
Journal: BMC pulmonary medicine
Published: January 19, 2020
A case of pulmonary tumor thrombotic microangiopathy associated with lung cancer diagnosed by cell-block immunohistochemistry of pulmonary microvascular cytology.
Journal: Respiratory medicine case reports
Published: June 03, 2019
Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: a case report.
Journal: BMC pulmonary medicine
Published: April 10, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026